(Q36132014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Alexander DR

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1128-1134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902287%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403797

11 January 2020

exact match

0 references

cites work

Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Translocations involving anaplastic lymphoma kinase (ALK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Anaplastic lymphoma kinase proteins in growth control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma').

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Nucleophosmin regulates the stability and transcriptional activity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Interleukin 9 and its receptor: an overview of structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Identification of NPM-ALK interacting proteins by tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

AP-1: a double-edged sword in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

NPM/ALK downregulates p27Kip1 in a PI-3K-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

Overexpression of NPM–ALK induces different types of malignant lymphomas in IL-9 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

A Case of a Diffuse Large B-Cell Lymphoma of Plasmablastic Type Associated With the t(2;5)(p23;q35) Chromosome Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

7 January 2021

Fine-needle aspiration biopsy of anaplastic large cell lymphoma, small cell variant with prominent plasmacytoid features: case report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

7 January 2021

ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

7 January 2021

Humanbcr-abl gene has a lethal effect on embryogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

7 January 2021

Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403797

7 January 2021